NSE
Jagsonpal Pharmaceuticals LimitedJAGSNPHARM
Jagsonpal Pharmaceuticals Limited is an NSE-listed company (JAGSNPHARM).
AI-generated overview — verify before relying on it.
Net institutional flow
+₹0 Cr
Institutional buyers
1 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
Buy Back
ex 2026-05-04
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | JAGSNPHARMThis | +₹0 Cr | 10 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — JAGSNPHARM day by day
- 2026-05-04ActionBuy BackBuyback
- 2025-09-12ActionDividend - Rs 2.50 Per ShareDividend
- 2025-07-28BulkSELL · ₹14.7 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-07-28BulkBUY · ₹14.6 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-07-28BulkSELL · ₹10.1 CrHRTI PRIVATE LIMITED
- 2025-07-28BulkBUY · ₹10.3 CrHRTI PRIVATE LIMITED
- 2025-01-08ActionFace Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per ShareSplit
- 2024-11-29BulkBUY · ₹19.3 CrANKITA VISHAL SHAH
- 2024-11-29BulkSELL · ₹12 CrANKITA VISHAL SHAH
- 2024-09-13BlockBUY · ₹88 CrINFINITY PORTFOLIO HOLDINGS
- 2024-09-13BlockSELL · ₹88 CrINFINITY HOLDINGS
- 2024-09-13BulkBUY · ₹88 CrINFINITY PORTFOLIO HOLDINGS
- 2024-09-13BulkSELL · ₹88 CrINFINITY HOLDINGS
- 2024-09-06ActionDividend - Rs 5 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
No scored filings for JAGSNPHARM yet.
10 deals · 2024-09-13 → 2025-07-28
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-07-28 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹14.7 Cr |
| 2025-07-28 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹14.6 Cr |
| 2025-07-28 | HRTI PRIVATE LIMITED | Prop / churn | SELL | ₹10.1 Cr |
| 2025-07-28 | HRTI PRIVATE LIMITED | Prop / churn | BUY | ₹10.3 Cr |
| 2024-11-29 | ANKITA VISHAL SHAH | HNI / other | BUY | ₹19.3 Cr |
| 2024-11-29 | ANKITA VISHAL SHAH | HNI / other | SELL | ₹12 Cr |
| 2024-09-13 | INFINITY PORTFOLIO HOLDINGS | Institution | BUY | ₹88 Cr |
| 2024-09-13 | INFINITY HOLDINGS | Institution | SELL | ₹88 Cr |
| 2024-09-13 | INFINITY PORTFOLIO HOLDINGS | Institution | BUY | ₹88 Cr |
| 2024-09-13 | INFINITY HOLDINGS | Institution | SELL | ₹88 Cr |
10 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on JAGSNPHARM
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.